This week's Fierce Pharma is brought to you by PurpleLab.

Complimentary Whitepaper Download

Hi E, check out this Fierce
Whitepaper we think you'll like:

Winning the Long Game: Life Sciences Companies Must Focus on Market Access -- Not Just Clinical Trials

Discover how real-world data help life sciences companies implement market access strategies designed to get new drugs to patients who need them.

According to analysis from consulting firm Deloitte, more than 50% of life science company drug launches miss expectations due to market access challenges, and about 50% of these companies also struggle with an inadequate or incomplete understanding of market and customer needs.

To improve market access, companies need to ensure that needed treatments reach the right patients at the right times and at affordable prices. To accomplish this optimal market access, companies must work closely with payer organizations, which typically control over which drugs are embraced by providers and their patients. This paper describes how companies can leverage real world data to support market access strategies such as:

• Identifying the right payers for pilot programs
• Understanding payer preferences for specific drug classes or treatment pathways
• Segmenting markets by payer type to implement targeted intervention strategies